REXULTI (Otsuka America Pharmaceutical, Inc.)
(https://rexulti.com) 📸 Data Snapshot: June 19, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Trust theatre is nearly absent because the site relies on regulatory proof rather than social proof. While review_count is technically present in the metadata (ranging from 2 to 5), these are not displayed as marketing testimonials; instead, the site points toward external validation via FULL PRESCRIBING INFORMATION and the National Pregnancy Registry for Psychiatric Medications. The only marketing-led trust element is the caregiver story, which is transparently disclosed as a compensated ambassador role, neutralizing potential BS points.
The proof density is high, with a verified proof path to the FDA-approved label and specific financial data. The savings-cost page provides a granular breakdown of insurance types and expected copays, citing IQVIA LAAD data from December 2024 through November 2025. This ratio of verifiable evidence to vague assertion is superior to most B2B or consumer health sites.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /savings-cost/ | 5 | 0 |
| /mdd/ | 2 | 0 |
| /aad/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "https://schema.org",
"@type": "WebSite",
"name": "REXULTI Consumer Website",
"url": "https://www.rexulti.com/",
"hasPart": {
"@type": "MedicalWebPage",
"url": "https://www.rexulti.com/",
"name": "REXULTI® (brexpiprazole) | Patient Information Website",
"description": "Learn about REXULTI® (brexpiprazole), its uses and how it may help. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.",
"headline": "Could REXULTI help?",
"relatedLink": "https://www.rexulti.com/mdd https://www.rexulti.com/aad https://www.rexulti.com/us/sz https://www.rexulti.com/important-safety-information https://www.rexulti.com/savings-cost",
"primaryImageOfPage": "https://www.rexulti.com/sites/g/files/qhldwo10756/files/GettyImages-650146050%204.jpg",
"audience": {
"@type": "Patient",
"additionalName": "Consumer"
},
"hasPart": [
{
"@type": "MedicalWebPage",
"url": "https://www.rexulti.com/mdd",
"disambiguatingDescription": [
"REXULTI for MDD",
"REXULTI for Major Depression",
"REXULTI for depression"
],
"isPartOf": "https://www.rexulti.com/",
"mainEntity": {
"@type": "MedicalCondition",
"name": "Major Depressive Disorder",
"alternateName": [
"MDD",
"depression",
"Major Depressive Disorder"
],
"sameAs": "https://en.wikipedia.org/wiki/Major_depressive_disorder",
"possibleTreatment": {
"@type": "MedicalTherapy",
"drug": {
"@type": "Drug",
"name": "REXULTI® (brexpiprazole)",
"proprietaryName": "Rexulti",
"mainEntityOfPage": "https://www.rexulti.com/"
}
}
}
},
{
"@type": "MedicalWebPage",
"url": "https://www.rexulti.com/aad",
"disambiguatingDescription": [
"REXULTI for AAD",
"REXULTI for Alzheimer's",
"REXULTI for Dementia",
"REXULTI for agitation"
],
"isPartOf": "https://www.rexulti.com/",
"mainEntity": {
"@type": "MedicalCondition",
"name": "Agitation that may happen with dementia due to Alzheimer's disease",
"alternateName": [
"agitation in alzheimer's dementia",
"aad",
"agitation in dementia"
],
"sameAs": "https://en.wikipedia.org/wiki/Agitation_(dementia)",
"possibleTreatment": {
"@type": "MedicalTherapy",
"drug": {
"@type": "Drug",
"name": "REXULTI® (brexpiprazole)",
"proprietaryName": "Rexulti",
"mainEntityOfPage": "https://www.rexulti.com/"
}
}
}
},
{
"@type": "MedicalWebPage",
"url": "https://www.rexulti.com/us/sz",
"disambiguatingDescription": "REXULTI for Schizophrenia",
"isPartOf": "https://www.rexulti.com/",
"mainEntity": {
"@type": "MedicalCondition",
"name": "Schizophrenia",
"sameAs": "https://en.wikipedia.org/wiki/Schizophrenia",
"possibleTreatment": {
"@type": "MedicalTherapy",
"drug": {
"@type": "Drug",
"name": "REXULTI® (brexpiprazole)",
"proprietaryName": "Rexulti",
"mainEntityOfPage": "https://www.rexulti.com/"
}
}
}
}
],
"about": {
"@type": "Drug",
"name": "REXULTI® (brexpiprazole)",
"logo": "https://www.rexulti.com/sites/g/files/qhldwo10756/files/logo3x.png",
"manufacturer": "Otsuka America Pharmaceutical, Inc.",
"warning": "https://www.rexulti.com/important-safety-information",
"prescribingInfo": "https://otsuka-us.com/sites/g/files/qhldwo10991/files/media/static/Rexulti-PI.pdf",
"proprietaryName": "Rexulti",
"activeIngredient": "brexpiprazole",
"dosageForm": "Tablet",
"drugClass": {
"@type": "DrugClass",
"name": "Atypical Antipsychotics"
},
"administrationRoute": "Oral",
"prescriptionStatus": "https://schema.org/PrescriptionOnly",
"sameAs": "https://en.wikipedia.org/wiki/Brexpiprazole"
},
"mentions": {
"@type": "TreatmentIndication",
"name": "INDICATIONS",
"description": "REXULTI is indicated for: Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults, Treatment of schizophrenia in adults and pediatric patients ages 13 years and older, Treatment of agitation associated with dementia due to Alzheimer’s disease"
},
"specialty": "https://schema.org/Psychiatric",
"publisher": {
"@type": "Organization",
"name": "Otsuka America Pharmaceutical, Inc.",
"url": "https://otsuka-us.com/",
"brand": {
"@type": "Brand",
"name": "REXULTI®",
"logo": "https://www.rexulti.com/sites/g/files/qhldwo10756/files/logo3x.png"
}
}
}
}
/savings-cost/
{
"@context": "https://schema.org",
"@type": "WebPage",
"url": "https://www.rexulti.com/savings-cost",
"name": "REXULTI® (brexpiprazole) | Savings & Cost Information",
"description": "Discover the REXULTI Savings Card and download today! Terms and conditions apply. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.",
"headline": "REXULTI® (brexpiprazole) Savings & Cost",
"relatedLink": "https://www.rexulti.com/ https://www.rexulti.com/mdd https://www.rexulti.com/aad https://www.rexulti.com/us/sz https://www.rexulti.com/important-safety-information",
"significantLink": "https://www.rexultisavings.com/",
"audience": {
"@type": "Patient",
"additionalName": "Consumer"
},
"about": {
"@type": "Drug",
"name": "REXULTI® (brexpiprazole)",
"logo": "https://www.rexulti.com/sites/g/files/qhldwo10756/files/logo3x.png",
"manufacturer": "Otsuka America Pharmaceutical, Inc.",
"warning": "https://www.rexulti.com/important-safety-information",
"prescribingInfo": "https://otsuka-us.com/sites/g/files/qhldwo10991/files/media/static/Rexulti-PI.pdf",
"proprietaryName": "Rexulti",
"activeIngredient": "brexpiprazole",
"dosageForm": "Tablet",
"drugClass": {
"@type": "DrugClass",
"name": "Atypical Antipsychotics"
},
"administrationRoute": "Oral",
"prescriptionStatus": "https://schema.org/PrescriptionOnly",
"sameAs": "https://en.wikipedia.org/wiki/Brexpiprazole"
},
"mentions": {
"@type": "MedicalIndication",
"name": "INDICATION",
"description": "REXULTI is indicated for: Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults, Treatment of schizophrenia in adults and pediatric patients ages 13 years and older, Treatment of agitation associated with dementia due to Alzheimer’s disease"
},
"video": {
"@type": "VideoObject",
"name": "More about Medicare Part D",
"alternateName": "Have Medicare?",
"description": "Learn about Payment Phases",
"thumbnailUrl": "https://i.vimeocdn.com/video/1767429859-5ef0ad1ada9de6ce5c822201fde407b2ed364a74a51af136667236f01bb35917-d_640",
"embedUrl": "https://player.vimeo.com/video/893606097",
"duration": "PT245S",
"uploadDate": "2023-12-12T01:43:50-05:00"
},
"specialty": "https://schema.org/Psychiatric",
"publisher": {
"@type": "Organization",
"name": "Otsuka America Pharmaceutical, Inc.",
"url": "https://otsuka-us.com/",
"brand": {
"@type": "Brand",
"name": "REXULTI®",
"logo": "https://www.rexulti.com/sites/g/files/qhldwo10756/files/logo3x.png"
}
}
}
/mdd/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/mdd/#medwebpage",
"url": "https://www.rexulti.com/mdd",
"name": "REXULTI® (brexpiprazole) | Add On Depression Medication",
"description": "Discover REXULTI, an add-on treatment for adults with major depressive disorder. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.",
"disambiguatingDescription": [
"REXULTI for MDD",
"REXULTI for depression",
"REXULTI add on depression medication",
"REXULTI for major depressive disorder"
],
"primaryImageOfPage": {
"@type": "ImageObject",
"@id": "https://www.rexulti.com/mdd/#primaryimage",
"url": "https://www.rexulti.com/sites/g/files/qhldwo13186/files/HeroHomeMddImageMobile.png",
"width": 300,
"height": 364,
"caption": "REXULTI for depression user smiling while holding smiley face sign."
},
"isPartOf": {
"@type": "WebSite",
"@id": "https://www.rexulti.com/#website",
"url": "https://www.rexulti.com/"
},
"about": [
{
"@type": "MedicalCondition",
"@id": "https://www.rexulti.com/mdd/depression-partial-response/#medcondition"
},
{
"@id": "https://www.rexulti.com/#drug"
}
],
"mentions": {
"@id": "https://www.rexulti.com/mdd/#indication"
},
"relatedLink": [
"https://www.rexulti.com/mdd/why-rexulti",
"https://www.rexulti.com/mdd/talk-to-your-doctor",
"https://www.rexulti.com/mdd/depression-symptom-questionnaire",
"https://www.rexulti.com/mdd/managing-depression",
"https://www.rexulti.com/mdd/tools-resources",
"https://www.rexulti.com/mdd/questions-answers",
"https://www.rexulti.com/mdd/depression-partial-response",
"https://www.rexulti.com/mdd/important-safety-information",
"https://www.rexulti.com/mdd/registration",
"https://www.rexulti.com/mdd/tv",
"https://www.rexulti.com/mdd/video-series",
"https://www.rexulti.com/mdd/video-series/episode-1",
"https://www.rexulti.com/mdd/video-series/episode-2",
"https://www.rexulti.com/mdd/video-series/episode-3",
"https://www.rexulti.com/mdd/video-series/episode-4",
"https://www.rexulti.com/mdd/video-series/episode-5",
"https://www.rexulti.com/mdd/video-series/episode-6"
],
"medicalAudience": {
"@type": "MedicalAudience",
"name": "Patients",
"healthCondition": {
"@type": "MedicalCondition",
"@id": "https://www.rexulti.com/mdd/depression-partial-response/#medcondition"
}
},
"publisher": {
"@id": "https://otsuka-us.com/#organization"
}
},
{
"@type": "Drug",
"@id": "https://www.rexulti.com/#drug",
"name": "REXULTI® (brexpiprazole)",
"sameAs": [
"https://www.wikidata.org/wiki/Q2924764",
"https://en.wikipedia.org/wiki/Brexpiprazole"
],
"logo": {
"@type": "ImageObject",
"@id": "https://www.rexulti.com/#logo"
},
"manufacturer": {
"@id": "https://otsuka-us.com/#organization"
},
"brand": {
"@id": "https://www.rexulti.com/#brand"
},
"warning": "https://www.rexulti.com/mdd/important-safety-information",
"prescribingInfo": "https://otsuka-us.com/media/static/Rexulti-PI.pdf",
"proprietaryName": "Rexulti",
"isProprietary": true,
"activeIngredient": "brexpiprazole",
"drugClass": {
"@type": "DrugClass",
"name": "Atypical Antipsychotics"
},
"dosageForm": "Tablet",
"administrationRoute": "Oral",
"relevantSpecialty": "https://schema.org/Psychiatric",
"prescriptionStatus": "https://schema.org/PrescriptionOnly"
},
{
"@type": "ApprovedIndication",
"@id": "https://www.rexulti.com/mdd/#indication",
"name": "Major Depressive Disorder",
"description": "REXULTI is a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. It is not known if REXULTI is safe and effective in children with MDD.",
"url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d301358-6291-4ec1-bd87-37b4ad9bd850",
"sameAs": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422Orig1Orig2s000lbl.pdf",
"code": {
"@type": "MedicalCode",
"codeValue": "F32.9",
"codingSystem": "ICD-10"
},
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration (FDA)",
"url": "https://www.fda.gov"
}
},
{
"@type": "Organization",
"@id": "https://otsuka-us.com/#organization",
"name": "Otsuka America Pharmaceutical, Inc.",
"logo": {
"@type": "ImageObject",
"@id": "https://otsuka-us.com/#logo",
"url": "https://www.otsuka-us.com/sites/g/files/qhldwo12546/themes/site/themes/custom/otsuka_corp/logo.svg",
"width": 75,
"height": 31,
"caption": "Ostuka logo"
},
"url": "https://otsuka-us.com/",
"brand": {
"@id": "https://www.rexulti.com/#brand"
},
"sameAs": [
"https://www.facebook.com/OtsukaUS",
"https://twitter.com/otsukaus",
"https://www.instagram.com/otsuka_us/",
"https://www.threads.net/@otsuka_us",
"https://www.youtube.com/@otsukaus416"
]
},
{
"@type": "Brand",
"@id": "https://www.rexulti.com/#brand",
"name": "REXULTI®",
"url": "https://www.rexulti.com/",
"logo": {
"@type": "ImageObject",
"@id": "https://www.rexulti.com/#logo",
"url": "https://www.rexulti.com/sites/g/files/qhldwo12851/files/logo%403x.png",
"width": 600,
"height": 261,
"caption": "Rexulti logo"
},
"description": "REXULTI is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults; to treat agitation that may happen with dementia due to Alzheimer’s disease"
}
]
}
/aad/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": [
"WebPage",
"MedicalWebPage"
],
"@id": "https://www.rexulti.com/aad/#medwebpage",
"url": "https://www.rexulti.com/aad",
"name": "REXULTI® (brexpiprazole) | agitation that may happen with dementia due to Alzheimer’s disease",
"description": "Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info & Full Prescribing Info, including Boxed WARNING.",
"headline": "Learn about agitation that may happen with dementia due to Alzheimer's disease.",
"disambiguatingDescription": [
"REXULTI for AAD",
"REXULTI for Alzheimer's",
"REXULTI for Dementia",
"REXULTI for agitation"
],
"breadcrumb": {
"@id": "https://www.rexulti.com/aad/#breadcrumb"
},
"hasPart": {
"@id": "https://www.rexulti.com/aad/#header-navigation"
},
"relatedLink": [
"https://www.rexulti.com/aad/why-rexulti",
"https://www.rexulti.com/aad/living-with-agitation-in-alzheimers",
"https://www.rexulti.com/aad/symptom-questionnaire",
"https://www.rexulti.com/aad/doctor-discussion-guide",
"https://www.rexulti.com/aad/resources-and-organizations",
"https://www.rexulti.com/aad/frequently-asked-questions",
"https://www.rexulti.com/aad/important-safety-information",
"https://www.rexulti.com/aad/helpful-videos",
"https://www.rexulti.com/aad/caregiver-registration",
"https://www.rexulti.com/aad/disease-impact"
],
"medicalAudience": {
"@type": "MedicalAudience",
"audienceType": [
"Consumer",
"Caregiver"
],
"healthCondition": {
"@id": "https://www.rexulti.com/aad/living-with-agitation-in-alzheimers/#medcondition"
}
},
"about": [
{
"@type": "Drug",
"@id": "https://www.rexulti.com/#drug"
},
{
"@type": "MedicalCondition",
"@id": "https://www.rexulti.com/aad/living-with-agitation-in-alzheimers/#medcondition"
},
{
"@id": "https://www.rexulti.com/aad/#indication"
}
],
"publisher": {
"@id": "https://otsuka-us.com/#organization"
},
"specialty": {
"@type": "MedicalSpecialty",
"name": "Psychiatry"
}
},
{
"@type": "TreatmentIndication",
"@id": "https://www.rexulti.com/aad/#indication",
"name": "Agitation that may happen with dementia due to Alzheimer’s disease",
"description": "REXULTI is a prescription medicine used to treat agitation that may happen with dementia due to Alzheimer’s disease. REXULTI should not be used as an “as needed” treatment for agitation that may happen with dementia due to Alzheimer’s disease.",
"url": "https://www.agitationinalz.com/",
"sameAs": [
"https://www.wikidata.org/wiki/Q4692699",
"https://en.wikipedia.org/wiki/Agitation_(dementia)"
],
"code": {
"@type": "MedicalCode",
"codeValue": "F03.911",
"codingSystem": "ICD-10"
},
"relevantSpecialty": "https://schema.org/Psychiatric",
"recognizingAuthority": {
"@type": "Organization",
"name": "U.S. Food and Drug Administration (FDA)",
"url": "https://www.fda.gov"
}
},
{
"@type": "SiteNavigationElement",
"@id": "https://www.rexulti.com/aad/#header-navigation",
"name": "REXULTI AADAD Website Main Navigation",
"url": "https://www.rexulti.com/aad",
"isPartOf": {
"@id": "https://www.rexulti.com/aad/#medwebpage"
},
"hasPart": [
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/why-rexulti/#medwebpage",
"name": "Why Rexulti",
"url": "https://www.rexulti.com/aad/why-rexulti"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/living-with-agitation-in-alzheimers/#medwebpage",
"name": "About this Condition",
"url": "https://www.rexulti.com/aad/living-with-agitation-in-alzheimers"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/symptom-questionnaire/#medwebpage",
"name": "Symptom Questionnaire",
"url": "https://www.rexulti.com/aad/symptom-questionnaire"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/disease-impact/#medwebpage",
"name": "Disease Impact",
"url": "https://www.rexulti.com/aad/disease-impact"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/doctor-discussion-guide/#medwebpage",
"name": "Talk to your loved one's doctor",
"url": "https://www.rexulti.com/aad/doctor-discussion-guide"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/resources-and-organizations/#medwebpage",
"name": "Resources and Organizations",
"url": "https://www.rexulti.com/aad/resources-and-organizations"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/frequently-asked-questions/#faqpage",
"name": "Questions and Answers",
"url": "https://www.rexulti.com/aad/frequently-asked-questions"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/helpful-videos/#medwebpage",
"name": "Helpful Videos",
"url": "https://www.rexulti.com/aad/helpful-videos"
},
{
"@type": "MedicalWebPage",
"@id": "https://www.rexulti.com/aad/caregiver-registration/#medwebpage",
"name": "Share your caregiver story",
"url": "https://www.rexulti.com/aad/caregiver-registration"
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.rexulti.com/aad/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.rexulti.com/"
},
{
"@type": "ListItem",
"position": 2,
"name": "AAD",
"item": "https://www.rexulti.com/aad/"
}
]
},
{
"@type": "Organization",
"@id": "https://otsuka-us.com/#organization",
"name": "Otsuka America Pharmaceutical, Inc.",
"url": "https://otsuka-us.com/",
"logo": {
"@type": "ImageObject",
"@id": "https://otsuka-us.com/#logo",
"url": "https://www.otsuka-us.com/sites/g/files/qhldwo12546/themes/site/themes/custom/otsuka_corp/logo.svg",
"width": 75,
"height": 31,
"caption": "Ostuka logo"
},
"brand": {
"@id": "https://www.rexulti.com/#brand"
},
"sameAs": [
"https://www.facebook.com/OtsukaUS",
"https://twitter.com/otsukaus",
"https://www.instagram.com/otsuka_us/",
"https://www.threads.net/@otsuka_us",
"https://www.youtube.com/@otsukaus416"
]
},
{
"@type": "Brand",
"@id": "https://www.rexulti.com/#brand",
"name": "REXULTI®",
"url": "https://www.rexulti.com/",
"logo": {
"@type": "ImageObject",
"@id": "https://www.rexulti.com/#logo",
"url": "https://www.rexulti.com/sites/g/files/qhldwo12851/files/logo%403x.png",
"width": 600,
"height": 261,
"caption": "Rexulti logo"
},
"description": "REXULTI is a prescription medicine used: along with antidepressant medicines to treat major depressive disorder (MDD) in adults; to treat agitation that may happen with dementia due to Alzheimer’s disease"
}
]
}
This page presents a snapshot of public data from REXULTI (Otsuka America Pharmaceutical, Inc.), captured on June 19, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to REXULTI (Otsuka America Pharmaceutical, Inc.): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://rexulti.com to view the most current version of its content and see directly what this company is about and what it offers.